Multiple first-in-human trials showed functional and biomarker improvements in early data reported at ASGCT's annual meeting.

Eli Lilly is turning up the volume on gene therapy with a $1.3 billion partnership with Rznomics to tackle sensorineural ...

The FDA's full approval of Nuvaxovid triggered a $175 million milestone payment to Novavax from Sanofi, related to their ...

In higher eukaryotes, a vast variety of RNAs is transcribed from genomic DNAs. The transcribed RNAs are subjected to RNA processing steps, such as splicing, ...

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with rising incidence linked to dietary and lifestyle changes.

The following is a summary of “Profiling Long Noncoding RNA in Psoriatic Skin Using Single-Cell RNA Sequencing,” published in ...

UC Irvine scientists developed bioluminescent RNA tags, "tiny guiding lights," using luciferase to track RNA in real-time, ...

Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies for sensorineural hearing loss, with milestone payments exceeding $1.3 billion.

Newly discovered weapons of bacterial self-defense take different approaches to achieving the same goal: preventing a virus from spreading through the bacterial population.

Our premium News+ ad-free experience – only $10 more every 4 weeks!

An international research team has discovered a critical protein that acts as a 'switch' regulating immune responses to viruses.

Adam Kovalčík figured out how to make an antiviral drug for a fraction of the normal cost, using an alcohol from corn husks.